134 related articles for article (PubMed ID: 16892030)
21. Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification.
Watanabe Y; Yasui K; Nakano T; Doi K; Fukada Y; Kitayama M; Ishimoto M; Kurihara S; Kawashima M; Fukuda H; Adachi Y; Inoue T; Nakashima K
Brain Res Mol Brain Res; 2005 Apr; 135(1-2):12-20. PubMed ID: 15857664
[TBL] [Abstract][Full Text] [Related]
22. Swelling and vacuolisation of mitochondria in transgenic SOD1-ALS mice: a consequence of supranormal SOD1 expression?
Jaarsma D
Mitochondrion; 2006 Feb; 6(1):48-9; author reply 50-1. PubMed ID: 16410057
[No Abstract] [Full Text] [Related]
23. Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?
Butsch PO; Cudkowicz ME
Exp Neurol; 2007 Jul; 206(1):11-5. PubMed ID: 17498699
[No Abstract] [Full Text] [Related]
24. Copper, zinc superoxide dismutase (SOD1) and its role in neuronal function and disease with particular relevance to motor neurone disease/amyotrophic lateral sclerosis.
de Belleroche J; Orrell RW; Virgo L; Habgood J; Gardiner IM; Malaspina A; Kaushik N; Mitchell J; Greenwood J
Biochem Soc Trans; 1998 Aug; 26(3):476-80. PubMed ID: 9765899
[No Abstract] [Full Text] [Related]
25. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS.
Zheng C; Nennesmo I; Fadeel B; Henter JI
Ann Neurol; 2004 Oct; 56(4):564-7. PubMed ID: 15389897
[TBL] [Abstract][Full Text] [Related]
27. Edaravone in ALS.
Takahashi R
Exp Neurol; 2009 Jun; 217(2):235-6. PubMed ID: 19285071
[No Abstract] [Full Text] [Related]
28. Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1.
Jonsson PA; Graffmo KS; Brännström T; Nilsson P; Andersen PM; Marklund SL
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1126-36. PubMed ID: 17146286
[TBL] [Abstract][Full Text] [Related]
29. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences.
Kato S
Acta Neuropathol; 2008 Jan; 115(1):97-114. PubMed ID: 18026741
[TBL] [Abstract][Full Text] [Related]
30. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
31. Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice.
Zhang X; Chen S; Li L; Wang Q; Le W
Neuropharmacology; 2008 Jun; 54(7):1112-9. PubMed ID: 18436268
[TBL] [Abstract][Full Text] [Related]
32. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.
Jonsson PA; Ernhill K; Andersen PM; Bergemalm D; Brännström T; Gredal O; Nilsson P; Marklund SL
Brain; 2004 Jan; 127(Pt 1):73-88. PubMed ID: 14534160
[TBL] [Abstract][Full Text] [Related]
33. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.
Kira Y; Nishikawa M; Ochi A; Sato E; Inoue M
Brain Res; 2006 Jan; 1070(1):206-14. PubMed ID: 16412993
[TBL] [Abstract][Full Text] [Related]
34. [Molecular mechanisms of amyotrophic lateral sclerosis: recent contributions from studies in animal models].
Dupuis L; Muller A; Meininger V; Loeffler JP
Rev Neurol (Paris); 2004 Jan; 160(1):35-43. PubMed ID: 14978392
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases--a conceptional alternative for disease-modifying strategies in ALS/MND?
Ludolph AC
Exp Neurol; 2006 Oct; 201(2):277-80. PubMed ID: 16808915
[No Abstract] [Full Text] [Related]
36. Facial onset sensory motor neuronopathy (FOSMN) syndrome: an unusual amyotrophic lateral sclerosis phenotype?
Vucic S
J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):951. PubMed ID: 24643461
[No Abstract] [Full Text] [Related]
37. Axonal degeneration in motor neuron disease.
Fischer LR; Glass JD
Neurodegener Dis; 2007; 4(6):431-42. PubMed ID: 17934327
[TBL] [Abstract][Full Text] [Related]
38. [Motor neuron disease up-to date].
Yamamoto M; Ishigaki S; Katsuno M; Sobue G
No To Shinkei; 2005 Apr; 57(4):273-83. PubMed ID: 15948399
[No Abstract] [Full Text] [Related]
39. Complex genetics of amyotrophic lateral sclerosis.
Kunst CB
Am J Hum Genet; 2004 Dec; 75(6):933-47. PubMed ID: 15478096
[No Abstract] [Full Text] [Related]
40. Mouse model found for ALS.
Marx J
Science; 1994 Jun; 264(5166):1663-4. PubMed ID: 8209242
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
